About this trial
Patients with advanced rectal cancer can sometimes have suspected tumour affected lymph nodes outside the standard operating field. These patients often receive preoperative treatment before surgery. There is a lack of consensus on what to do if there is remaining suspicion of tumour affected lymph nodes after the preoperative treatment. Removal of the lymph nodes using a broader surgical field with dissection of the lateral side-wall is often suggested, but the oncologic outcome is uncertain, and so is the patient reported outcome in terms of side effects.
This study aims to study the surgical treatment of tumour affected lateral lymph nodes to understand what lymph nodes require removal, and what effect that will have on oncologic outcome and the patient's function and QoL.
Eligibility criteria
Qualifiers
18 years or older
written informed consent
adenocarcinoma verified tumour below ≤ 8 cm from anal verge measured by rectoscopy and/or MRI
clinical tumor (cT) stage cT3, cT4a or cT4b on MRI or
Disqualifiers
Not biopsy confirmed rectal cancer (adenocarcinoma)
Recurrent rectal cancer
Age below 18
Participation in other trials in conflict with the protocol and end-points of the Latitude study
Trial design
Treatments tested in this trial
- Lateral lymph node dissection
Treatment groups
Sponsors and collaborators
Sahlgrenska University Hospital
Lead sponsor
Göteborg University
Collaborator